Home
Scholarly Works
Impact of concurrent angiotensin inhibitors on...
Conference

Impact of concurrent angiotensin inhibitors on outcomes with PD1/L1 inhibitors for patients (pts) with metastatic urothelial carcinoma (mUC).

Authors

Agarwal A; Pond GR; Curran C; Nassar A; Nuzzo PV; Kumar V; McGregor BA; Wei XX; Harshman LC; Choueiri TK

Volume

38

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

May 20, 2020

Name of conference

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Conference place

ELECTR NETWORK

Conference start date

May 29, 2020

Conference end date

May 31, 2020

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team